McAdam LLC’s Moderna MRNA Stock Holding History

McAdam LLC’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,768	Closed	-$489K	–	373
2024 Q4	$489K	Buy	11,768 +562	+5%	+$26.9K	0.03%	207
2024 Q3	$749K	Buy	11,206 +131	+1%	+$12K	0.04%	155
2024 Q2	$1.32M	Buy	11,075 +117	+1%	+$14.8K	0.08%	103
2024 Q1	$1.17M	Sell	10,958 -39	-0.4%	-$3.93K	0.07%	107
2023 Q4	$1.09M	Buy	10,997 +2,529	+30%	+$213K	0.08%	102
2023 Q3	$875K	Buy	8,468 +562	+7%	+$62.7K	0.07%	117
2023 Q2	$961K	Buy	7,906 +1,092	+16%	+$146K	0.08%	112
2023 Q1	$1.05M	Buy	6,814 +3,094	+83%	+$510K	0.09%	108
2022 Q4	$945K	Sell	3,720 -1,399	-27%	-$229K	0.09%	79
2022 Q3	$605K	Buy	5,119 +754	+17%	+$114K	0.07%	120
2022 Q2	$624K	Buy	4,365 +159	+4%	+$22.7K	0.07%	122
2022 Q1	$725K	Buy	4,206 +486	+13%	+$81.8K	0.07%	94
2021 Q4	$945K	Buy	3,720 +1,336	+56%	+$391K	0.09%	79
2021 Q3	$918K	Sell	2,384 -22	-0.9%	-$8.11K	0.1%	76
2021 Q2	$832K	Buy	2,406 +106	+5%	+$18.9K	0.09%	76
2021 Q1	$301K	Buy	+2,300	New	+$333K	0.04%	120

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return